Please login to the form below

Not currently logged in
Email:
Password:

British National Formulary moves to NICE

The National Institute for Health and Clinical Excellence is to take over responsibility for the British National Formulary from the Department of Health

The National Institute for Health and Clinical Excellence (NICE) is to take over responsibility for the British National Formulary (BNF) from the Department of Health (DH).

The move comes as a result of the Darzi review and the establishment of a new service, NHS Evidence, which aims to bring clinical information and evidence together, offering healthcare professionals and patients good quality information in one place.

As the independent organisation responsible for providing national guidance on public health, health technologies and clinical practice, NICE will take over responsibility for the BNF.

Dr Gillian Leng, interim chief operating officer for NHS Evidence and NICE deputy chief executive, said: "We are delighted that the BNF will become a key part of NHS Evidence at NICE. NICE is looking forward to working in partnership with the BNF to ensure that it continues to provide high quality and clinically relevant advice."

The BNF provides independent, authoritative information about the use of medicines and is a key reference source for doctors, pharmacists and other healthcare professionals.
 

16th December 2008

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics